Author information:
(1)Department of Neurology and Stroke Medicine, Yokohama City University 
Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, 
Japan. hdoi@yokohama-cu.ac.jp.
(2)Department of Neurology and Stroke Medicine, Yokohama City University 
Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, 
Japan.
(3)Department of Human Genetics, Yokohama City University Graduate School of 
Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
(4)Clinical Genetics Department, Yokohama City University Hospital, Yokohama, 
236-0004, Japan.
(5)Department of Pharmacology, National Defense Medical College, 3-2 Namiki, 
Tokorozawa, Saitama, 359-8513, Japan.
(6)Department of Genome Repair, Atomic Bomb Disease Institute, Nagasaki 
University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
(7)Department of Environmental Immuno-Dermatology, Yokohama City University 
Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, 
Japan.
(8)Department of Pediatrics, National Hospital Organization Higashisaitama 
Hospital, Hasuda, 4147 Kurohama, Saitama, 349-0196, Japan.
(9)Department of Neurology, National Hospital Organization Higashisaitama 
Hospital, Hasuda, 4147 Kurohama, Saitama, 349-0196, Japan.
(10)Department of Genetics, Research Institute of Environmental Medicine, Nagoya 
University, Furo-cho, Chikusa-ku, Nagoya, 464-8601, Japan.
(11)Department of Neurology and Stroke Medicine, Yokohama City University 
Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, 
Japan. ftanaka@yokohama-cu.ac.jp.